Synthetic lethality may help overcome cancer therapeutic resistance by exploiting tumour vulnerabilities, supported by ...
Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s ...
Cancer represents a key challenge in medical science, manifesting as a disease where the immune system fails to recognize and eliminate tumor cells. The phenomenon of immune evasion by cancer cells ...
This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to ...
US FDA grants Orphan Drug Designation to Adolore BioTherapeutics’ Kv7-activating rdHSV-CA8 therapy to treat erythromelalgia: Delray Beach, Florida Friday, January 16, 2026, 17:0 ...
Three seniors at Horace Greeley High School — Brady Wang, Kevin Guo and Warren Fu — have been named a Top 300 Scholar in the ...
While resistance is a natural evolutionary process, the review shows that human activity has dramatically intensified its ...
ImmunityBio, Inc. today announced an update on the status of enrollment in its randomized registrational trial in BCG-naïve ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
With 80% of the rural population considered medically underserved as of 2025, the number of U.S. residents without optimal ...
Company also announces renaming of Toliara Project to Vara Mada to better reflect the project's positive benefits to Madagascar and its global importance as a major new source of titanium, zircon, and ...
News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results